Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival
Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival Chen, G. Q., Huynh, M., Fehrenbacher, L., Davies, A. M., West, H., Gordon, P., Pan, M., Russin, M., Lara, P. N., Gandara, D. R., Lau, D. H. AMER SOC CLINICAL ONCOLOGY. 2008View details for DOI 10.1200/jco.2008.26.15_suppl.19009
View details for Web of Science ID 000208457402944